Literature DB >> 17320159

Family history of cancer and utilization of prostate, colorectal and skin cancer screening tests in U.S. men.

Mona Shah1, Kangmin Zhu, Richard C Palmer, Hongyu Wu.   

Abstract

BACKGROUND: For cancers related to genetic factors, screening may be particularly important for individuals who have a family history of the disease. This study examined whether men with a family history of cancer were more likely to utilize prostate, colorectal or skin cancer screenings compared to those without a family history.
METHODS: The data for this study came from male respondents who participated in the 2000 National Health Interview Survey. The age range of the study subjects and the definitions of cancer screening were determined based on the American Cancer Society recommendations on cancer screening.
RESULTS: Men who had a family history of colorectal cancer were twice more likely to utilize colorectal cancer screening than men without a family history of the disease. Compared to men without a family history of prostate cancer, men with a family history were more likely to undergo a PSA examination. The association of family history with colorectal and prostate cancer screening was stronger among younger men.
CONCLUSIONS: Family history of cancer was highly associated with colorectal and prostate cancer screening examinations in U.S. men. This may reflect more physicians' recommendations and a higher motivation to get a screening test for men with a family history of cancer.

Entities:  

Mesh:

Year:  2007        PMID: 17320159     DOI: 10.1016/j.ypmed.2006.12.016

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  9 in total

Review 1.  Screening participation for people at increased risk of colorectal cancer due to family history: a systematic review and meta-analysis.

Authors:  Driss Ait Ouakrim; Trevor Lockett; Alex Boussioutas; John L Hopper; Mark A Jenkins
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

2.  Understanding preventive behaviors among mid-Western African-American men: a pilot qualitative study of prostate screening.

Authors:  Idethia Shevon Harvey; Reginald J Alston
Journal:  J Mens Health       Date:  2011-05-01       Impact factor: 0.537

3.  Racial and ethnic variations in the effects of family history of colorectal cancer on screening compliance.

Authors:  Molly Perencevich; Rohit P Ojha; Ewout W Steyerberg; Sapna Syngal
Journal:  Gastroenterology       Date:  2013-06-22       Impact factor: 22.682

4.  Impact of colon cancer screening on family history phenotype.

Authors:  Polly A Newcomb; Anamaria Savu; Amanda I Phipps; Anna E Coghill; Yutaka Yasui
Journal:  Epidemiology       Date:  2012-03       Impact factor: 4.822

5.  Pathological aggressiveness of prostatic carcinomas related to RNASEL R462Q allelic variants.

Authors:  Benjamin T Larson; Cristina Magi-Galluzzi; Graham Casey; Sarah J Plummer; Robert Silverman; Eric A Klein
Journal:  J Urol       Date:  2008-03-04       Impact factor: 7.450

6.  Effect of a detailed family history of melanoma on risk for other tumors: a cohort study based on the nationwide Swedish Family-Cancer Database.

Authors:  Tianhui Chen; Mahdi Fallah; Elham Kharazmi; Jianguang Ji; Kristina Sundquist; Kari Hemminki
Journal:  J Invest Dermatol       Date:  2013-11-05       Impact factor: 8.551

7.  Colonoscopy screening among US adults aged 40 or older with a family history of colorectal cancer.

Authors:  Meng-Han Tsai; Sudha Xirasagar; Yi-Jhen Li; Piet C de Groen
Journal:  Prev Chronic Dis       Date:  2015-05-21       Impact factor: 2.830

8.  The Relation among Prostate Cancer Knowledge and Psychosocial Factors for Prostate Cancer Screening among African American Men: a Correlational Study.

Authors:  Sabrina L Dickey; Aurellia Whitmore; Ellen Campbell
Journal:  AIMS Public Health       Date:  2017-10-25

9.  Prostate specific antigen test uptake: a cross sectional study on elderly men in Western Iran.

Authors:  Mehdi Mirzaei-Alavijeh; Farzad Jalilian; Laleh Solaimanizadeh; Abdollah Saadatfar; Shima Khashij; Razieh Pirouzeh; Farzaneh Solaimanizadeh
Journal:  BMC Geriatr       Date:  2020-08-24       Impact factor: 3.921

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.